연구동향 분석
박사

심혈관질환에 대한 유자의 효능 검증 및 기전 연구 : Protective Effects of Yuzu and Its Component against Cardiovascular Disease

유혜연 2015년

논문상세정보
인용/피인용
' 심혈관질환에 대한 유자의 효능 검증 및 기전 연구 : Protective Effects of Yuzu and Its Component against Cardiovascular Disease' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • apoptosis
  • cardiomyocyte
  • fibrosis
  • heart failure
  • hesperidin
  • inflammation
  • ischemic heart disease
  • left ventricular remodeling
  • platelet aggregation
  • yuzu
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,259 0

0.0%

' 심혈관질환에 대한 유자의 효능 검증 및 기전 연구 : Protective Effects of Yuzu and Its Component against Cardiovascular Disease' 의 참고문헌

  • van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J: Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7: 30-37, 2010
  • van Wijk B, Gunst QD, Moorman AF, van den Hoff MJ: Cardiac regeneration from activated epicardium. PLoS One 7: e44692. 2012
  • Yoo KM, Hwang IK, Park JH, Moon B: Major phytochemical composition of 3 native Korean citrus varieties and bioactive activity on V79-4 cells induced by oxidative stress. J Food Sci 74: C462-C468, 2009
  • Yi W1, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang X, Wang Y, Shang X, Gao E, Koch WJ, Ma XL: C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation 125: 3159-3169, 2012
  • Yang B, Ye D, Wang Y: Caspase-3 as a therapeutic target for heart failure. Expert Opin Ther Targets 17: 255-263, 2013
  • Yamazaki KG, Taub PR, Barraza-Hidalgo M, Rivas MM, Zambon AC, Ceballos G, Villarreal FJ: Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J Am Coll Cardiol 55: 2869-2876, 2010
  • Yamazaki KG, Romero-Perez D, Barraza-Hidalgo M, Cruz M, Rivas M, Cortez- Gomez B, Ceballos G, Villarreal F: Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 295: H761-H767, 2008
  • Vaidyula VR, Rao AK: Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Galphaq and phospholipase C-beta2. Br J Haematol 121: 491- 496, 2003
  • Tang WH, Shrestha K, Troughton RW, Borowski AG, Klein AL: Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure. Congest Heart Fail 17: 105-109, 2011
  • Sutton MG, Sharpe N: Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2998, 2000
  • Strauer BE, Yousef M, Schannwell CM: The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heart failure: the STAR-heart study. Eur J Heart Fail 12: 721-729, 2010
  • Seo EJ, Lee DU, Kwak JH, Lee SM, Kim YS, Jung YS: Antiplatelet effects of Cyperus rotundus and its component (+)-nootkatone. J Ethnopharmacol 135(1): 48- 54, 2011
  • Rein D, Paglieroni TG, Pearson DA, Wun T, Schmitz HH, Gosselin R, Keen CL: Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 130: 2120S-2126S, 2000
  • Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O: Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J 33: 2360-2369, 2012
  • Paulus WJ: Cytokines and heart failure. Heart Fail Monit 1: 50-56, 2000
  • O'Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK: Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr, 84: 570-579, 2006
  • Nieswandt B, Aktas B, Moers A, Sachs UJ: Platelets in atherothrombosis: lessons from mouse models. J. Thromb Haemost 3: 1725-1736, 2005
  • Navarro-N ez L, Lozano ML, Palomo M, Mart nez C, Vicente V, Castillo J, Benavente-Garc a O, Diaz-Ricart M, Escolar G, Rivera J: Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. J Agric Food Chem 56: 2970-2976, 2008
  • Nagarajan V, Tang WH: Biomarkers in advanced heart failure: diagnostic and therapeutic insights. Congest Heart Fail 17(4): 169-174, 2011
  • Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP: Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKC delta in platelets. Blood 106: 550-557, 2005
  • Lal H, Zhou J, Ahmad F, Zaka R, Vagnozzi RJ, Decaul M, Woodgett J, Gao E, Force T: Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post61 myocardial infarction remodeling and death. Circulation 125: 65-75, 2012
  • Konstantinidis K, Whelan RS, Kitsis RN: Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32: 1552-1562, 2012
  • Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE: Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4: 98-108, 2011
  • Kim SJ, Li M, Jeong CW, Bae HB, Kwak SH, Lee SH, Lee HJ, Heo BH, Yook KB, Yoo KY: Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats. Arch Pharm Res 37:1079-1085, 2014
  • Kim MY, Seo EJ, Lee DH, Kim EJ, Kim HS, Cho HY, Chung EY, Lee SH, Baik EJ, Moon CH, Jung YS: Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia. Cardiovasc Res 87: 119-126, 2010
  • Kim JS, Lee KS, Kim YI, Tamai Y, Nakahata R, Takami H: A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test. J Clin Neurosci 11: 600-602, 2004
  • Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA: Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46: 2116-2124, 2005
  • Kandasamy AD, Chow AK, Ali MA, Schulz R: Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res 85: 413-423, 2010
  • Jin YR, Han XH, Zhang YH, Lee JJ, Lim Y, Chung JH, Yun YP: Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLCgamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 194: 144- 152, 2007
  • Jessup M, Brozena: Heart failure. N Engl J Med 348: 2007-2018, 2003
  • Jennings LK: Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost, 102: 248-257. 2009
  • Hirota R, Roger NN, Nakamura H, Song HS, Sawamura M, Suganuma N: Antiinflammatory effects of limonene from yuzu (Citrus junos Tanaka) essential oil on eosinophils. J Food Sci 75: H87-H92, 2010
  • Hardy AR, Jones ML, Mundell SJ, Poole AW: Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 104: 1745-1752, 2004
  • Han Y, Li Y, Wang S, Jing Q, Wang Z, Wang D, Shu Q, Tang X: Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. Am Heart J 157: 733-739, 2009
  • Goto S: Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl 6: 3-11, 2005
  • Gonz lez A, Ravassa S, Beaumont J, L pez B, D ez J: New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58: 1833-1843. 2011
  • Garg A, Garg S, Zaneveld LJ, Singla AK: Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res 15: 655-669, 2001
  • Gao E1, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ: A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107: 1445-1453, 2010
  • Gadi D, Bnouham M, Aziz M, Ziyyat A, Legssyer A, Legrand C, Lafeve FF, Mekhfi H: Parsley extract inhibits in vitro and ex vivo platelet aggregation and prolongs bleeding time in rats. J Ethnopharmacol 125: 170-174, 2009
  • Fuster V, Sweeny JM: Aspirin: a historical and contemporary therapeutic overview. Circulation 123: 768-778, 2011
  • Farndale RW, Sixma JJ, Barnes MJ, de Groot PG: The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2: 561-573, 2004
  • Eapen Z, Rogers JG: Strategies to attenuate pathological remodeling in heart failure. Curr Opin Cardiol 24: 223-229, 2009
  • Dorn GW 2nd, Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodeling. Cardiovasc Res 81: 465-473, 2009
  • Diwan A, Tran T, Misra A, Mann DL: Inflammatory mediators and the failing heart: a translational approach. Curr Mol Med 3: 161-182, 2003
  • Dav G, Patrono C: Platelet activation and atherothrombosis. N Engl J Med 357,:2482-2494, 2007
  • Creemers EE, Cleutjens JP, Smits JF, Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ Res 89: 201-210, 2001
  • Cho J, Furie BC, Coughlin SR, Furie B: Acritical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 118: 1123- 1131. 2008
  • Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group: Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 366: 1607-1621, 2005
  • Chanet A, Milenkovic D, Deval C, Potier M, Constans J, Mazur A, Bennetau57 Pelissero C, Morand C, B rard AM: Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice. J Nutr Biochem J Nutr Biochem 23(5): 469-477, 2012
  • Cazenave JP, Ohlmann P, Cassel D, Eckly A, Hechler B, Gachet C : Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol 272: 13-28, 2004
  • Campian ME, Hardziyenka M, de Bruin K, van Eck-Smit BL, de Bakker JM, Verberne HJ, Tan HL: Early inflammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail 12: 653-658, 2010
  • Brass LF: Thrombin and platelet activation. Chest 124: 18S-25S, 2003
  • Benavente-Garc a O, Castillo J : Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agri. Food Chem. 56: 6185-6205, 2008
  • Anatoliotakis N, Deftereos S, Bouras G, Giannopoulos G, Tsounis D, Angelidis C, Kaoukis A, Stefanadis C: Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease. Curr Top Med Chem 13: 115-138, 2013
  • ?1. Akhlaghi M, Bandy B: Dietary broccoli sprouts protect against myocardial oxidative damage and cell death during ischemia-reperfusion. Plant Foods Hum Nutr. 65: 193-199, 2010